Mammalian Cell Engineering with Viral Vector Barcodes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current technologies face challenges in efficiently producing viral vectors in mammalian cells and in isolating optimized cell lines for biologics production, due to inefficient viral production and cumbersome screening processes.
Innovation Solution
The development of platform technologies for engineering mammalian cells and viral vectors, which include methods for producing and selecting cell lines with improved characteristics for viral vector expression, such as increased expression, duration, and stability. This is achieved by incorporating identifiers, such as barcode sequences, into the cells and viral vectors, allowing for efficient evaluation and characterization of viral vector production capacity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional screening methods are used to isolate optimized mammalian cell lines, then cell line selection can be achieved, but the process is cumbersome and inefficient
Solution Approach 1:
The patent applies preliminary action by pre-incorporating unique identifiers (barcodes) into the mammalian cell lines before viral vector production. This allows for pre-characterization and tracking of cell lines, enabling efficient screening and selection without complex post-production analysis. The identifiers are integrated into the cell genome alongside viral vector production machinery, so that when viral vectors are produced, they carry corresponding identifiers that link back to the parent cell line's characteristics.
Solution Approach 2:
The patent uses copying by transferring the unique identifier from the mammalian cell line into the viral vector genome. This creates a molecular copy that travels with the viral vector, allowing researchers to trace which cell line produced which viral vectors. This copying mechanism eliminates the need for complex screening procedures, as the identifier automatically provides information about the parent cell line's production capacity and characteristics.
2Productivity
If mammalian cells are engineered for viral vector production, then production capacity increases, but characterization and evaluation of production capacity becomes difficult
Solution Approach 1:
The patent implements feedback by creating a direct molecular link between the mammalian cell line and its produced viral vectors through unique identifiers. The identifier in the viral vector provides immediate feedback about the parent cell line's characteristics and production capacity. This allows researchers to evaluate and characterize production capacity efficiently by simply analyzing the identifiers in the viral vectors, without needing complex additional assays or characterization methods.
3Reliability
If traditional methods are used for isolating cell lines, then optimized cell lines can be obtained, but manufacturing costs remain high
Solution Approach 1:
The patent reduces manufacturing costs by using molecular copying of identifiers instead of complex screening and characterization procedures. The unique identifier copied into viral vectors eliminates the need for expensive and time-consuming traditional screening methods to evaluate and select optimized cell lines. This copying approach provides reliable cell line optimization data at a fraction of the cost of traditional methods.
Data Source
AI summary
The present disclosure provides mammalian cell lines for expression of viral vectors, and methods of making and using the same. Provided methods employ use of identifiers that are capable of being packaged into a viral vector to select and/or identify mammalian cell lines with engineered sequences associated with beneficial characteristics for viral vectors production. Exemplary viral vectors include AAV vectors.